Cushing's disease; Cushing's syndrome; Multiple endocrine neoplasia type 1; Carney complex; Familial isolated pituitary adenomas; Aryl hydrocarbon receptor-interacting protein
Résumé :
[en] Cushing's syndrome (CS) is characterized by pathologically elevated free glucocorticoid levels. Endogenous hypercortisolism is usually due to ACTH-secreting pituitary corticotropic adenomas and less often due to ectopic ACTH-secreting neuroendocrine neoplasms or ACTH-independent adrenal cortisol hypersecretion. CS is a serious chronic disease leading to a several-fold increase in cardiovascular morbidity and mortality. Multiple genetic alterations have been described in the setting of sporadic corticotropinoma formation. Changes in the expression profiles have been demonstrated in growth factors and their receptors, cell-cycle regulators and in various genes related to hormonal gene transcription, synthesis and secretion. Sporadic adrenal adenomas and carcinomas may demonstrate dysfunction in genes such as TP53 among others. Cushing's disease can be an inherited condition also. Multiple endocrine neoplasia type 1 (MEN1) and familial isolated pituitary adenomas (FIPA) together account for 5% of pituitary adenomas. Cushing's disease occurs infrequently in an inherited setting in both of these conditions. To date only 2 cases of Cushing's disease have been described in association with mutations in AIP. One case of Cushing's disease has been reported as part of MEN4, a rare MEN1-like syndrome due to mutation in the CDKN1B gene. Carney complex (CNC) due to PRKAR1A mutations in most cases is associated with CS, mainly as a cause of bilateral adrenal hyperplasia. The cAMP signaling pathway is affected in this setting. In recent times the involvement of genes such as PDE11A, PDE8B and others have expanded the spectrum of the genetic pathophysiology of CS.
Morris, D.G., Kola, B., Borboli, N., Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas (2003) J Clin Enodocinol Metab, 88, pp. 6080-6087
Dahia, P.L., Honegger, J., Reincke, M., Expression of glucocorticoid receptor gene iso-forms in corticotropin-secreting tumors (1997) J Clin Endocrinol Metab, 82, pp. 1088-1093
Dieterich, K.D., Gundelfinger, E.D., Ludecke, D.K., Mutation and expression analysis of corticotropin-releasing factor 1 receptor in adrenocorticotropin-secreting pituitary adenomas (1998) J Clin Endocrinol Metab, 83, pp. 3327-3331
De Keyzer, Y., Rene, P., Beldjord, C., Over-expression of vasopressin (V3) and cortico-trophin-releasing hormone receptor gene in corticotroph tumors (1998) Clinical Endocrinology, 49, pp. 475-482
Rabbitt, E.H., Ayuk, J., Boelaert, K., Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: A prereceptor determinant of pituitary cell proliferation (2003) Oncogene, 22, pp. 1663-1667
Drouin, J., Bilodeau, S., Valette, S., Of old and new disease: Genetics of pituitary ACTH excess (Cushing) and deficiency (2007) Clin Genet, 72, pp. 175-182
Bilodeau, S., Valette-Kasic, S., Gaut Hier, Y., Role of Brg1 and H DAC2 i n GR t rans-repres-sion of the pituitary POMC gene and misex-pression in Cushing's disease (2006) Genes Dev, 20, pp. 2871-2886
Burgess, J.R., Greenaway, T.M., Shepherd, J.J., Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1 (1998) J Intern Med, 243, pp. 465-470
Vergès, B., Boureille, F., Goudet, P., Pituitary disease in MEN type 1 (MEN1): Data from the France-Belgium MEN1 multicenter study (2002) J Clin Endocrinol Metab, 87, pp. 457-465
Pellegata, N.S., Quintanilla-Martinez, L., Sig-Gelkow, H., Germ-line mutations in p27Kip1 cause a multiple endocrine neopla-sia syndrome in rats and humans (2006) Proc Natl Acad Sci USA, 103, pp. 15558-15563
Georgitsi, M., Raitila, A., Karhu, A., Germ-line CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia (2007) J Clin Endocrinol Metab, 92, pp. 3321-3325
Daly, A.F., Jaffrain-Rea, M.L., Ciccarelli, A., Clinical characterization of familial isolated pituitary adenomas (2006) J Clin Endocrinol Metab, 91, pp. 3316-3323
Pereira, A.M., Hes, F.J., Horvath, A., Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families (2010) J Clin Endocri-nol Metab, 95, pp. 338-342
Kirschner, L.S., Carney, J.A., Pack, S.D., Mutations of the gene encoding the protein ki-nase A type I-alpha regulatory subunit in patients with the Carney complex (2000) Nat Genet, 26, pp. 89-92
Kirschner, L.S., Sandrini, F., Monbo, J., Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex (2000) Hum Mol Genet, 9, pp. 3037-3046
Groussin, L., Kirschner, L.S., Vincent-Dejean, C., Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: Augmented PKA sig-na ling i s ass o c iated wit h adrena l t umor igen-esis in PPNAD (2002) A M J Hum Genet, 71, pp. 1433-1442
Groussin, L., Jullian, E., Perlemoine, K., Mutations of the PRKAR1A gene in Cush-ing's syndrome due to sporadic primary pig-mented nodular adrenocortical disease (2002) J Clin Endocrinol Metab, 87, pp. 4324-4329
Horvath, A., Boikos, S., Giatzakis, C., A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individua ls with adrenocortica l hy perplasia (2006) Nat Genet, 38, pp. 794-800
Lacroix, A., ACTH-independent macronodu-lar adrenal hyperplasia (2009) Best Pract Res Clin Endocrinol Metab, 23, pp. 245-259
Bourdeau, I., Matyakhina, L., Stergiopoulos, S.G., 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotro-pin-independent macronodular adrenal hy-perplasia (2006) J Clin Endocrinol Metab, 91, pp. 3626-3632
Hsiao, H.P., Verma, S., Boikos, S.A., A molecular and clinical genetic investigation of ACTH-independent macronodular ad rena l hyperplasia compared to other common ad-renocortical tumors: Evidence for heterogeneity overlap with other tumor syndromes and frequent but atypical hormonal secretion (2007) 89th Annual Meeting of the Endocrine Society Toronto, p. 403. , abstr P2-299
Gicquel, C., Leblond-Francillard, M., Bertagna, X., Clonal analysis of human adrenocor-tical carcinomas and secreting adenomas (1994) Clin Endocrinol (Oxf), 40, pp. 465-477
Bertherat, J., Bertagna, X., Pathogenesis of ad-renocortical cancer (2009) Best Pract Res Clin En-docrinol Metab, 23, pp. 261-271
Lam, W.W., Hatada, I., Ohishi, S., Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiede-mann syndrome (BWS) provides a novel genotype-phenotype correlation (1999) J Med Genet, 36, pp. 518-523
Gicquel, C., Bertagna, X., Gaston, V., Molecular markers and long-term recurrences i n a la rge cohor t of pat ients w it h sporad ic ad-renocortical tumors (2001) Cancer Res, 61, pp. 6762-6767
Libe, R., Groussin, L., Tissier, F., Somatic TP53 mutations are relatively rare among ad-renocortical cancers with the frequent 17p13 loss of heterozygosity (2007) Clin Cancer Res, 13, pp. 844-850
Latronico, A.C., Pinto, E.M., Domenice, S., An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors (2001) J Clin Endocrinol Metab, 86, pp. 4970-4973
Tissier, F., Cavard, C., Groussin, L., Mutations of beta-catenin in adrenocortical tumors: Activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors (2005) Cancer Res, 65, pp. 7622-7627
